Hong Kong Investment Highlights: Tencent's Q2 Adjusted Net Profit Up 9% to 68.4 Billion Yuan, Capital Expenditure Surges to 52.8 Billion Yuan, Free Cash Flow Turns Negative

Financial Results Snapshot

TENCENT (00700) released its second-quarter results, with adjusted profit attributable to shareholders reaching 68.415 billion yuan, a year-on-year increase of 9%.

Cheung Kong Infrastructure Holdings (01038) posted interim results, with profit attributable to shareholders of 21.252 billion Hong Kong dollars, surging 388.78% year-on-year.

POWER ASSETS (00006) reported interim results, with profit attributable to shareholders of 14.704 billion Hong Kong dollars, a 383.37% increase from the previous year.

GALAXY ENT (00027) announced interim results, reporting a profit attributable to shareholders of 5.3 billion Hong Kong dollars, up 1% year-on-year.

Bloks Group (00325) released its 2026 interim results, with a net profit of 387 million yuan, a 30.5% increase year-on-year.

Nexteer Automotive (01316) reported interim results, with profit attributable to equity holders of 85.806 million US dollars, a 35.17% rise year-on-year.

Yue Yuen Industrial (00551) posted interim results, with profit attributable to shareholders of 71.998 million US dollars, a 57.9% decline year-on-year. An interim dividend of 0.4 Hong Kong dollars was declared.

Pou Sheng International (03813) released its 2026 interim results, with profit attributable to shareholders of 244 million yuan, up 29.9% year-on-year.

Changhong Jiahua (03991) reported interim results, with profit attributable to shareholders of 206 million Hong Kong dollars, a 13.52% increase year-on-year.

WeRide (00800) posted second-quarter results, with total revenue of 232 million yuan, surging 82.2% year-on-year.

Dmall Inc. (02586) released interim results, with profit attributable to shareholders of 109 million yuan, a 60.85% increase year-on-year.

Datang New Energy (01798) issued a profit warning, expecting its interim net profit attributable to shareholders to be between 675 million yuan and 705 million yuan, a decrease of approximately 58% to 60% from the prior year.

China Resources Medical (01515) expects its interim profit attributable to shareholders to be between 252 million yuan and 278 million yuan, a decline of approximately 18.1% to 25.9% year-on-year.

MicroPort Scientific (00853) issued a profit warning, expecting to record a net loss for the interim period.

Key Corporate Developments

CATL (03750) plans to invest 2.475 billion yuan to participate in the Hainan Times Green Industry Fund, aiming to expand its layout in the carbon neutrality ecosystem.

Zhenhe Medical-B (02697) has won a scientific research procurement project from Yunnan Agricultural University for its multi-organ, multi-sensor normothermic perfusion system.

Hengrui Medicine (01276) announced that its drug candidates SHR-7590 and HRS-4729 injections have received clinical trial approval notices.

DEEPEXI TECH (01384) plans to raise approximately 500 million Hong Kong dollars through a share placement at 35 Hong Kong dollars per share, to bolster its enterprise AI agent and Token productivity platform development.

Samsonite (01910) intends to acquire an 85% interest in Beis for 178.5 million US dollars, strengthening its footprint in the North American lifestyle travel sector.